DocDollars

Fresenius Kabi USA, LLC

IL · United States · Reporting entity ID 100000010706

Total reported 2019–2025
$9.12M
#521 of 2,960 reporting companies — 0% of all reported industry payments
$6.10M in general payments across 24,246 records, plus $3.02M in research funding across 600 records.

How it breaks down

General payments $6,103,457
Research funding $3,016,845

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Fresenius Kabi USA, LLC reported $9.12M to US doctors and teaching hospitals from 2019 to 2025, ranking #521 of 2,960 reporting companies. 33% of that was research funding and 67% general payments such as consulting, speaking, food and travel. 24,246 general payment records and 600 research records were filed.

Common questions about Fresenius Kabi USA, LLC

How much has Fresenius Kabi USA, LLC paid US doctors?

Fresenius Kabi USA, LLC reported $9,120,302 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,103,457 in general payments, $3,016,845 in research funding.

How does Fresenius Kabi USA, LLC rank among drug and device companies?

It ranks #521 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Fresenius Kabi USA, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.